UNITED KINGDOM SOCIETY FOR EXTRACELLULAR VESICLES
Advancement of public education and the promotion of those branches of science concerned with extracellular vesicles. 1. Provision of a forum for the promotion of research within the field of extracellular vesicles, including discussion, conferences, meetings, public outreach2. Providing grants to charitable institutions and individuals for the purpose of furthering any of these objects
Financial health, per its FY2025 accounts
The charity reports unrestricted reserves of £56,884, which it holds to ensure it can run its annual conference if commercial sponsorship is insufficient. The trustees state the charity remains in a healthy financial position to continue planning core activities for 2025, with no material uncertainties affecting its going concern status.
What the accounts disclose
“Reserves are held to ensure that we are able to run our annual conference in the event that we are not able to find enough commercial sponsors to keep ticket costs to a minimum”
Trustees
- David Carterchair
- Dr Charlotte Lawson
- Dr Daniel Lambert
- Dr Jason Webber
- Dr Lesley Smyth
- Dr Manu Vatish DPhilFRCOG
- Dr PAUL HARRISON
- Dr Rachel Crossland
- Dr Ryan Pink
- Dr Stuart Hunt
- Dr Victoria James
- Professor Aled Clayton
- Professor Andrew Devitt
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 01/04/2025 | £37k | £33k |
| 01/04/2024 | £36k | £35k |
| 01/04/2023 | £36k | £34k |
| 01/04/2022 | £8k | £5k |
| 01/04/2021 | £24k | £5k |
Common questions
Is UNITED KINGDOM SOCIETY FOR EXTRACELLULAR VESICLES financially healthy?
Per its FY2025 accounts: The charity reports unrestricted reserves of £56,884, which it holds to ensure it can run its annual conference if commercial sponsorship is insufficient. The trustees state the charity remains in a healthy financial position to continue planning core activities for 2025, with no material uncertainties affecting its going concern status. Its FY2025 accounts were independently examined.